Improved AAV tropism is essential for gene therapy to reach its full potential. New capsid engineering techniques are taking on this challenge. Clinical translation of gene therapies has a history ...

Underpinning Voyager’s mission is its trademark AAV capsid-discovery platform, Tropism Redirection of AAV by Cell-type-specific Expression of RNA (TRACER). This broadly applicable, functional ...

A small group of intensively studied AAV capsids have been propelled into pre-clinical and clinical use, and more recently, marketed products; however, many less-studied, naturally occurring capsids ...